Medicine
Quinapril 40 mg tablet
Quinapril 40 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Quinapril
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 3000 tablets, 10 blister pack and 8 more
- Manufacturers
- Aurobindo PharmaIndiaCiplaIndiaBluePoint LaboratoriesChartwell RXNorthwind HealthSolco Healthcare7 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09AA06 Quinapril
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 March 2005
- Identifiers
- RxCUI 312748, 312749, 312750 +1DailyMed set ID 8ded0773-3aec-4e89-9836-d22a5a84abf0, cd46691d-5593-4a9f-a937-999c6803e312, e6d36e1e-8e35-4d06-83dc-45e0456365fd +4NDC 68180-559, 43547-413, 69097-843 +5Application ANDA077690, ANDA205823, ANDA078457 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 65862-620-30 | Aurobindo PharmaIndia | 29 April 2013 |
| 3000 tablet, film coated in 1 bottle | 65862-620-39 | Aurobindo PharmaIndia | 29 April 2013 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-620-78 | Aurobindo PharmaIndia | 29 April 2013 |
| 90 tablet, film coated in 1 bottle | 65862-620-90 | Aurobindo PharmaIndia | 29 April 2013 |
| 1000 tablet, film coated in 1 bottle | 65862-620-99 | Aurobindo PharmaIndia | 29 April 2013 |
| 90 tablet in 1 bottle | 69097-843-05 | CiplaIndia | 22 July 2016 |
| 1000 tablet in 1 bottle | 69097-843-15 | CiplaIndia | 22 July 2016 |
| 90 tablet, film coated in 1 bottle | 62135-487-90 | Chartwell RX | 6 November 2023 |
| 90 tablet in 1 bottle | 43547-413-09 | Solco Healthcare | 10 November 2017 |
| 90 tablet in 1 bottle | 68001-260-05 | BluePoint Laboratories | 18 July 2014 |
| 30 tablet in 1 bottle, plastic | 51655-737-52 | Northwind Health | 19 July 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 November 1991 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Quinapril
Clinical summary
Quinapril is an angiotensin converting enzyme inhibitor indicated for the treatment of hypertension, to lower blood pressure. It is available as tablets for oral use. MedsAcross supplies Quinapril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about QuinaprilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Quinapril prescribing information (Aurobindo Pharma) · U.S. National Library of Medicine, DailyMed
Need Quinapril 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.